A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Repeat-dose Study of the Safety and Efficacy of OxyADF (oxycodone HCl and niacin) Tablets for the Treatment of Acute, Moderate to Severe Postoperative Pain Following Bunionectomy Surgery in Adult Patients

Trial Profile

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Repeat-dose Study of the Safety and Efficacy of OxyADF (oxycodone HCl and niacin) Tablets for the Treatment of Acute, Moderate to Severe Postoperative Pain Following Bunionectomy Surgery in Adult Patients

Completed
Phase of Trial: Phase III

Latest Information Update: 21 May 2011

At a glance

  • Drugs Oxycodone/niacin (Primary)
  • Indications Pain; Postoperative pain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Acura Pharmaceuticals
  • Most Recent Events

    • 21 May 2011 Results presented at the 30th Annual Scientific Meeting of the American Pain Society.
    • 19 May 2009 Results presented at the 28th Annual Scientific Meeting of the American Pain Society (APS), as reported by a King Pharmaceuticals media release.
    • 09 May 2009 Results presented at the 28th Annual Scientific Meeting of the American Pain Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top